Trends in Use of Cardioprotective Medication in Peripheral Artery Disease: A Nationwide Study.

ABSTRACT: Background Guideline-based cardioprotective medical therapy is intended to reduce the burden of adverse cardiovascular and limb outcomes in patients with peripheral artery disease (PAD). However, contemporary data describing trends in use of medication remains limited. The present study, therefore, aims to investigate changes in use of cardioprotective medication in PAD. Methods and Results By using Danish national healthcare registries, we identified all patients with first-time diagnosis of PAD (1997-2016) and classified them into two groups: (1) PAD+ that includes all patients with PAD with a history of cardiovascular disease, ie, myocardial infarction, atrial fibrillation, and stroke (n=162 627); and (2) PAD (n=87 935) that comprise patients without a history of cardiovascular disease.

SUBMITTER: Kamil S 

PROVIDER: S-EPMC8475709 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature